Primary purpose: The overarching goal of the study is to address child second-hand-smoke exposure by supporting parent smoking cessation. For that purpose, the investigators designed the present investigator-blinded, randomized controlled clinical trial, to be carried out in real-world settings, in order to test the effectiveness of two combined interventions, one to promote smoking cessation and another to support parents with unmet social needs, which could be hindering their smoking cessation efforts.
Rationale: In Canada, tobacco use is the greatest cause of preventable morbidity and mortality, generating attributable annual health-related costs of CAD $16.2 billion and 48 thousand deaths. Parental smoking has direct impacts on child health, starting at in-utero stages (e.g., fetal growth restriction, premature birth, sudden infant death syndrome, and exacerbation of respiratory illnesses) and it contributes to child and adolescent smoking initiation. Yet, despite its well-known negative effects, 15% of Canadian children are exposed to household second-hand smoke. Data also indicate that parents are overall underserved in terms of medical care and see their child(ren)'s medical care providers more often than their own, but they are not frequently screened for smoking (less than 5% of visits to pediatric practices) nor do they receive any smoking cessation support. Yet, twenty-five percent of all adult smokers have children who are seen in child healthcare offices. Further, smoking and social economic status (SES) are strongly associated, such that populations with lower SES present higher proportions of tobacco use, indicating lower SES can be an obstacle to smoking cessation as well as a perpetuating factor for smoking.
Aims and hypotheses:
Aim 1 - Examining the effectiveness of the intervention (CanCEASE + HN) on smoking cessation compared to care-as-usual. Hypothesis 1: the intervention will lead to a higher proportion of quits among smoking parents than the control condition.
Aim 2 - Examining the effectiveness of the intervention (HN) on unmet social needs and, if so, does the resolution of an unmet social need mediate CanCEASE-related smoking cessation. Hypotheses: (2a) there will be a greater decrease in the prevalence of unmet social needs in the intervention vs. control arm; (2b) resolution of unmet social need(s) will mediate in part the effect of the intervention on smoking cessation.
Aim 3 - Assessing whether the intervention (CanCEASE + HN) implemented as planned is acceptable to participants and practices. Hypotheses: (3a) both intervention and control will be acceptable to participants and practices where they are implemented; (3b) both the intervention and control will be delivered as planned to most participants.
Aim 4 - Examining the incremental cost-effectiveness ratio in Canadian dollars per quit of CanCEASE with HN compared to care-as-usual. Hypothesis 4: The intervention will have a favorable cost per quit compared to control.
Participant recruitment: Participants (N=1000) will be recruited from pediatric outpatient clinics in two healthcare centres in Montreal, Canada (i.e., General pediatrics outpatient clinic, CHU Sainte-Justine; Outpatient pediatric clinics, Hôpital Maisonneuve-Rosemont). Potential participants will initially undergo a brief pre-screening process that should take under a minute to complete. It is designed for initial identification of parents who smoke using questions about data on relationship of the child with the accompanying adult, smoking status of the adult and contact information. This first pass prevents adults in the clinic from spending too much time in activities unrelated to their visit and prevents disruption of the work flow at the recruiting sites. Pre-screening can be completed via the study website, self-check-in stations in the recruitment sites (where available), and via the hospital appointment confirmation systems. Alternatively, pre-screening will be conducted by an on-site research assistant when parents come to register for an appointment. Recruitment will also be done via referral by the clinical or front desk teams either by having interested individuals fill out an "authorization to contact form" or by scanning a QR code from posters that will be placed in the clinics, such that the research team can contact potential participants to present the study, obtain informed consent, assess them for social risks to determine if the individual is eligible to participate in the study.
Intervention: CanCEASE is a parental smoking cessation intervention that facilitates referral and linkage to existing healthcare and community resources and it is available in both French and English. It consists of (1) asking about smoking status, (2) a self-assessment of readiness to quit, and interest in available resources, (3) providing advice on available services with brief motivational messages, (4) assistance to quit, via quit lines and text message support, and (5) assistance with access to Nicotine Replacement Therapy (NRT). Participants will be randomized either to the control or the intervention arm of the study. In both arms, participants will complete three questionnaires, one within the first month after recruitment, then 6 and 12 months later. CanCEASE will be offered after the end of each questionnaire to participants in the intervention arm of the study and after the 12-month questionnaire to control participants. Control group will receive care-as-usual, depending on what is typically available on site, and at recruitment, a resource list with freely available cessation resources with advice on how to obtain NRT. Participants in the intervention group will receive, in addition to CanCEASE, two support sessions a health navigator (HN). HNs are individuals trained in specific areas of health, but who do not necessarily hold a professional degree. Their role is to provide assistance in ways that are complementary to what an individual receives from the healthcare system. HNs can potentially enhance smoking cessation efforts by facilitating access to resources and supporting participants facing poverty-related challenges that hinder their cessation efforts. Participants are expected to commit to at least two sessions with the HN, the initial evaluation and follow up. Session 1 will take place about 14 days after baseline questionnaire, according to participant availability. It will consist of an evaluation, information session, specification of quitting goals and specifying unmet social needs. During and, if needed, on the days following the session, the HN will facilitate participant access to resources and send support materials as needed. Session 2 will occur about a month after baseline questionnaire, according to participant availability. At this time, the HN will go over the current smoking and unmet needs status, inquire about barriers and challenges, and will follow-up on referrals and resources that were previously provided. Participants are free to book additional HN sessions as needed for as long as they are actively taking part in the study. After every session, participants will receive a satisfaction survey to fill out. Whenever a participant reports having quit smoking, they will be invited to provide a urine sample for lab confirmation that there is no longer any nicotine in their system. Urine samples will be self-collected and sent by accelerated postage.
Relevance: This RCT will compare, in families with unmet social needs, the effectiveness and cost-effectiveness of the CanCEASE intervention for parental smoking cessation with HN support in comparison to care as usual plus information on freely available cessation resources. It could yield data that supports leveraging implementation of preventive primary care to improve population health.
